CAS 144689-63-4
:olmésartan médoxomil
- (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylate
- (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}imidazaole-5-carboxylate
- (5-Methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-([4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl)-1H-imidazole-5-carboxylate
- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-ethyl-2-propyl-1-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate
- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl.5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
- 1,3-Dioxole, 1H-imidazole-5-carboxylic acid deriv.
- 1H-Imidazole-5-Carboxylic Acid, 4-(1-Hydroxy-1-Methylethyl)-2-Propyl-1-[[2'-(1H-Tetrazol-5-Yl)[1,1'-Biphenyl]-4-Yl]Methyl]-, (5-Methyl-2-Oxo-1,3-Dioxol-4-Yl)Methyl Ester
- 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- 2-Butyl-4-(1-hydroxy-1-methylethyl)-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- 4-(1-Hydroxy-1-Methylethyl)-2-Propyl-1-[[2'-(1H-Tetazol-5-Yl)[1,1'-Biphenyl]-4-Yl]Methyl]-1H-Imidazole-5-Carboxylic Acid (5-Methyl-2-Oxo-1,3-Dioxol-4-Yl)Methyl Ester
- 4-(1-Hydroxy-1-Methylethyl)-2-Propyl-1-[[2'-(1H-Tetrazol-5-Yl)[1,1'-Biphenyl]-4-Yl]Methyl]-1H-Imidazole-5-Carboxylic Acid (5-Methyl-2-Oxo-1,3-Dioxol-4-Yl)Methyl Ester
- Angiosartan
- Benicar
- Cs-866
- Medoxomil
- Olmesartan Medoximil
- Olmetec
- Olsertain
- Omst
- Olmesartan medoxomil
- 5-(1-HYDROXY-1-METHYLETHYL)-2-PROPYL-3-[2''-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-3H-IMIDAZOLE-4-CARBOXYLIC ACID 5-METHYL-2-OXO-[1,3]DIOXOL-4-YLMETHYL ESTER
- CS-866, 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2(1H-tetazol-5-yl)[1,1biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester
- 5-(1-Hydroxy-1-methylethyl)-2-propyl-3-[2'-(1H-tet
- OlmesartanC29H30N6O6
- OLMESARTAN
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylicacid(5-Methyl-2-oxo-1,3-dioxol-4-yl)methylester
- Voir plus de synonymes
Olmesartan Medoxomil
CAS :Formule :C29H30N6O6Degré de pureté :>98.0%(T)(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :558.60Olmesartan medoxomil
CAS :Olmesartan medoxomilFormule :C29H30N6O6Degré de pureté :99.7%Couleur et forme :White. To. Light YellowMasse moléculaire :558.22268OLMESARTAN MEDOXOMIL CRS
CAS :OLMESARTAN MEDOXOMIL CRSFormule :C29H30N6O6Couleur et forme :PowderMasse moléculaire :558.5851OLMESARTAN MEDOXOMIL FOR SYSTEM SUITABILITY CRS
CAS :OLMESARTAN MEDOXOMIL FOR SYSTEM SUITABILITY CRSFormule :C29H30N6O6Couleur et forme :PowderMasse moléculaire :558.5851Olmesartan Medoxomil
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C29H30N6O6Couleur et forme :White Light Yellow PowderMasse moléculaire :558.22268Olmesartan Medoxomil
CAS :Olmesartan Medoxomil (Benicar) is an angiotensin II type 1 receptor blocker that is used to manage hypertension.Formule :C29H30N6O6Degré de pureté :99.89% - 99.9%Couleur et forme :White To Off-White Crystalline PowderMasse moléculaire :558.59Ref: TM-T1518
5mg34,00€10mg50,00€25mg57,00€50mg63,00€100mg93,00€200mg137,00€500mg260,00€1mL*10mM (DMSO)55,00€1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
CAS :Formule :C29H30N6O6Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :558.5851Olmesartan Medoxomil
CAS :Formule :C29H30N6O6Couleur et forme :White To Off-White SolidMasse moléculaire :558.60Olmesartan medoxomil
CAS :Formule :C29H30N6O6Degré de pureté :98.0 - 102.0 % (dried basis)Couleur et forme :White to almost white powderMasse moléculaire :558.59Olmesartan Medoxomil
CAS :Produit contrôléFormule :C29H30N6O6Couleur et forme :NeatMasse moléculaire :558.59Olmesartan Medoxomil
CAS :Produit contrôléApplications An angiotensin II receptor antagonist. Used as an anti-hypertensive.
References Yanagisawa, H., et al.: J. Med. Chem., 39, 323 (1996), Puchler, K., et al.: J. Hypertens., 15, 1809 (1997),Formule :C29H30N6O6Couleur et forme :WhiteMasse moléculaire :558.59Olmesartan medoxomil
CAS :Olmesartan is a drug that belongs to the class of angiotensin II receptor antagonists. It is used for the treatment of high blood pressure, heart failure, and kidney disease. The therapeutic effect of olmesartan can be increased by concomitant use with other drugs if it is being used as a combination therapy. This drug interacts with many other drugs, including diuretics and ACE inhibitors. Drugs that are known to interact with olmesartan include furosemide, hydrochlorothiazide, amiloride, spironolactone, triamterene, chlorothiazide and quinethazone. Blood sampling is often required during therapy in order to monitor the efficacy of this drug.
Formule :C29H30N6O6Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :558.59 g/mol














